España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Vincent Andrews
FMC Announces 'Shocking' Outlook: 4 Analysts Dive Deeper Into Prospects
Morgan Stanley: Underperformance In DowDuPont Provides An Attractive Entry Point
Morgan Stanley Downgrades Albemarle Corp. On Supply, Pricing Concerns
Morgan Stanley: Underperformance In DowDuPont Provides An Attractive Entry Point
Morgan Stanley Downgrades Albemarle Corp. On Supply, Pricing Concerns
Morgan Stanley Resumes Coverage On Praxair As Discussions With Linde Dissolve
Potash Oversupply Makes Investments Uncertain In Short-Term, Morgan Stanley Says
Morgan Stanley Resumes Coverage On Praxair As Discussions With Linde Dissolve
Potash Oversupply Makes Investments Uncertain In Short-Term, Morgan Stanley Says
Monsanto: Morgan Stanley Still Likes Stock, But Cuts Target
What's Coming For Monsanto?
Read More...
Vincent Andrews Recent News
The Case For Monsanto At $120
UPDATE: Morgan Stanley Upgrades Mosaic Company On Multiple Positive Factors
Morgan Stanley Resumes Coverage On CF Industries
Morgan Stanley Revises Quarterly Estimates For RPM International
Morgan Stanley Sees Challenges Ahead In F2015 For Monsanto Company
Morgan Stanley Believes Strategic Shift In Phosphate Could Trump Negative Preannouncement For Mosaic Co
Morgan Stanley Sees High Quality Growth Story For Monsanto
UPDATE: Morgan Stanley Reiterates On CF Industries As Underperformance Should Begin To Reverse
UPDATE: Morgan Stanley Reiterates on Praxair Ahead of 1Q14 Results
Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company
UPDATE: Morgan Stanley Resumes Coverage on Agrium with Equal-Weight Rating on Lack of Catalysts
Morgan Stanley Sees Bunge Making Progress Toward Improving Its ROIC
Morgan Stanley is Not Surprised by 4Q Results from Intrepid Potash
Morgan Stanley Thinks Mosaic Shares Have Reacted Favorably to Recent News
Morgan Stanley Fears Expectations on Archer Daniels Midland May Be Too High
Morgan Stanley Reiterates Overweight on Monsanto Company Following F1Q14 Results
UPDATE: Morgan Stanley Resumes Coverage on Potash Corporation on Cautious Market Outlook
UPDATE: Morgan Stanley Downgrades Mosaic Following Potash Industry Shift
UPDATE: Morgan Stanley Maintains Equal-weight on Celanese on Methanol JV Announcements